Skip to main content
U.S. flag

An official website of the United States government

Return to Search

Coverage with Evidence Development

Guidance for updated guidance document that describes coverage with evidence development (CED). CMS, as part of the national coverage determination (NCD) may determine coverage of an item or service only in the context of a clinical study.

Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: January 30, 2020

CMS released an updated guidance document on August 7, 2024 that describes coverage with evidence development (CED). CMS, as part of the national coverage determination (NCD) may determine coverage of an item or service only in the context of a clinical study. The NCDs requiring CED are listed to the left - clicking on an NCD will lead to a listing of approved clinical studies for that specific NCD. Each NCD contains information on the status of CED.

A CED cycle is considered completed when CMS completes a reconsideration of the CED coverage decision and removes the requirement for the study participation as a condition of coverage. As with any NCD, any member of the public may request to reopen the NCD that requires CED. CMS prospectively plans to re-examine the published evidence at a date tied to completion of a CMS-approved CED study or other available evidence. CMS retains the right to reconsider an NCD at any time. CMS will review the evidence resulting from the CED studies as well as any other available evidence. The NCD process is described in the Federal Register (78 Fed. Reg. 48164).

The most recent CED Guidance is located here:  Coverage with Evidence Development

 

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.